Antiviral combo pill cures HCV in 8-12 weeks

LONDON – A single daily pill containing two novel antiviral agents produced sustained virologic response rates of more than 90% in as little as 8-12 weeks in three multicenter, open-label phase III...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.